press-releases

Lunaphore closes a CHF 5.3M Series B financing round

Date

Lunaphore Technologies SA, a Swiss medtech firm developing innovative next-generation devices for cancer tissue diagnostics*, announces closing of CHF 5.3M in Series B funding. Together with the CHF 6M convertible loan injected to the company in October 2017, the overall financing round amount has reached CHF 11.3M.

Read the full press release

Related Articles

Lunaphore and Bethyl Laboratories announce partnership to leverage library of primary antibodies on COMET™ platform and expand spatial biology services
Lunaphore and Bethyl Laboratories announce partnership to leverage library of primary antibodies on COMET™ platform and expand spatial biology services

Posted on 10 May 2023

Read Post
Lunaphore – a Bio-Techne brand announces new data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, underscoring the potential of the COMET™ portfolio in cancer research
Lunaphore – a Bio-Techne brand announces new data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, underscoring the potential of the COMET™ portfolio in cancer research

Posted on 01 Nov 2023

Read Post